INOVELON susp 40 mg/ml fl 460 ml
7680620660018
CH-62066
N03AF03
01.07.1.
Reimbursement limitations:
TALOXA
Syndrome de Lennox-Gastaut
1 / 3
google
Details
- Product number
- 6206601
- CPT
- -
- Packaging group
- 460
- Unit
- ml
- Composition
- rufinamidum 40 mg, sorbitolum liquidum non cristallisabile corresp. sorbitolum 175 mg, propylenglycolum 25 mg, cellulosum microcristallinum, carmellosum natricum, acidum citricum, hydroxyethylcellulosum, dimeticonum, polysorbatum 65, methylcellulosum, silica colloidalis hydrica, macrogoli stearas, E 210 max. 0.005 mg, E 200, acidum sulfuricum, poloxamerum 188, aromatica (Orange) cum alcohol benzylicus, E 202, E 218 1.2 mg, propylis parahydroxybenzoas 0.3 mg, aqua purificata, ad suspensionem pro 1 ml corresp. natrium max. 0.22 mg.
Articles (1)
Inovelon, Suspension zum Einnehmen
suspension
460
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
40.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
175.0 MG | Substance | HBESI |
|
(N/A)
|
25.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
1.2 MG | Substance | HBESI |
|
(N/A)
|
0.3 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 90.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2012
Authorization holder
Eisai Pharma AG
8050 Zürich
Authorization information
- Swissmedic authorization number
- 62066
- Drug name
- Inovelon, Suspension zum Einnehmen
- Galenic form
- SUOR
- ATC Code
- N03AF03
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 13/06/2012
- Authorization expiration date
- 31/12/9999
- IT number
- 01.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- INOVELON susp 40 mg/ml fl 460 ml
- Description (DE)
- INOVELON Susp 40 mg/ml Fl 460 ml
- Market launch
- 13/06/2012
- Narcotic (BTM)
- No